• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后骨质疏松症中的骨转换标志物及其与骨密度和绝经持续时间的相关性。

Bone turnover markers in postmenopausal osteoporosis and their correlation with bone mineral density and menopause duration.

作者信息

Gurban Camelia Vidiţa, Balaş Melania Olga, Vlad Mihaela Maria, Caraba Alexandru Emil, Jianu Adelina Maria, Bernad Elena Silvia, Borza Claudia, Bănicioiu-Covei Simona, Motoc Andrei Gheorghe Marius

机构信息

Department of Anatomy and Embryology, "Victor Babeş" University of Medicine and Pharmacy, Timişoara, Romania;

出版信息

Rom J Morphol Embryol. 2019;60(4):1127-1135.

PMID:32239087
Abstract

BACKGROUND

Biochemical bone turnover markers (BTMs) estimates the bone remodeling process, being valuable in the personalized approach of osteoporotic patients.

AIM

The aim of the study was to evaluate the correlation between biochemical BTMs and bone mineral density (BMD), depending on menopause period, in postmenopausal osteoporotic women, compared to postmenopausal women without osteoporosis.

PATIENTS, MATERIALS AND METHODS: The study included 149 untreated postmenopausal women, divided into three groups: group 1 (65 osteoporotic women with less than 10 years of menopause), group 2 (44 osteoporotic patients, with over 10 years of menopause), and the control group with 40 postmenopausal women without osteoporosis.

RESULTS

All BTMs levels were higher in the groups with osteoporosis, than in the control group. Lumbar BMD values correlated positively with deoxypyridinoline (DPD) and negatively with bone-specific isoform of alkaline phosphatase (BAP), tartrate-resistant acid phosphatase band 5b (TRAP 5b), osteocalcin (OC) and cross-linked N-telopeptides of type I collagen (NTX). Serum estradiol levels correlated positively with spine BMD in the whole study group (r=0.508, p=0.001). BTMs correlated positively with each other. Osteoporotic women with longer period of menopause presented significantly higher values of resorption markers (NTX and TRAP 5b), compared to the group with menopause duration less than 10 years. At a cutoff value of 12 μg∕L, BAP presented 82.4% sensitivity and 62.5% specificity.

CONCLUSIONS

Our study showed that BTMs correlated negatively with lumbar BMD and positively with each other. Resorption markers levels increase with duration of estradiol deprivation period.

摘要

背景

生化骨转换标志物(BTMs)可评估骨重塑过程,在骨质疏松患者的个性化治疗中具有重要价值。

目的

本研究旨在评估绝经后骨质疏松女性与无骨质疏松的绝经后女性相比,根据绝经时间,生化BTMs与骨密度(BMD)之间的相关性。

患者、材料与方法:本研究纳入149例未经治疗的绝经后女性,分为三组:第1组(65例绝经少于10年的骨质疏松女性),第2组(44例绝经超过10年的骨质疏松患者),以及对照组40例无骨质疏松的绝经后女性。

结果

骨质疏松组的所有BTMs水平均高于对照组。腰椎BMD值与脱氧吡啶啉(DPD)呈正相关,与骨特异性碱性磷酸酶同工型(BAP)、抗酒石酸酸性磷酸酶5b条带(TRAP 5b)、骨钙素(OC)和I型胶原交联N-端肽(NTX)呈负相关。在整个研究组中,血清雌二醇水平与脊柱BMD呈正相关(r=0.508,p=0.001)。BTMs之间呈正相关。与绝经持续时间少于10年的组相比,绝经时间较长的骨质疏松女性的骨吸收标志物(NTX和TRAP 5b)值显著更高。在截断值为12μg∕L时,BAP的敏感性为82.4%,特异性为62.5%。

结论

我们的研究表明,BTMs与腰椎BMD呈负相关,且彼此之间呈正相关。骨吸收标志物水平随雌二醇缺乏期的延长而增加。

相似文献

1
Bone turnover markers in postmenopausal osteoporosis and their correlation with bone mineral density and menopause duration.绝经后骨质疏松症中的骨转换标志物及其与骨密度和绝经持续时间的相关性。
Rom J Morphol Embryol. 2019;60(4):1127-1135.
2
Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis.绝经后骨质疏松症患者骨转换标志物、血清镁与骨密度的相关性。
Clin Interv Aging. 2018 Aug 3;13:1383-1389. doi: 10.2147/CIA.S170111. eCollection 2018.
3
Differences in bone resorption after menopause in Japanese women with normal or low bone mineral density: quantitation of urinary cross-linked N-telopeptides.日本绝经后骨密度正常或偏低女性的骨吸收差异:尿交联N-端肽的定量分析
Calcif Tissue Int. 1998 May;62(5):395-9. doi: 10.1007/s002239900451.
4
Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a cross-sectional study.沙特阿拉伯女性生化骨转换标志物参考区间的横断面研究。
Bone. 2010 Oct;47(4):804-14. doi: 10.1016/j.bone.2010.07.017. Epub 2010 Jul 23.
5
Relationship of bone turnover to bone density and fractures.骨转换与骨密度及骨折的关系。
J Bone Miner Res. 1997 Jul;12(7):1083-91. doi: 10.1359/jbmr.1997.12.7.1083.
6
Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.绝经后期女性骨转换增加是骨质疏松症的主要决定因素。
J Bone Miner Res. 1996 Mar;11(3):337-49. doi: 10.1002/jbmr.5650110307.
7
Bone turnover and its relationship with bone mineral density in pre- and postmenopausal women with or without fractures.有或无骨折的绝经前和绝经后女性的骨转换及其与骨密度的关系。
Maturitas. 1998 Jun 17;29(3):265-70. doi: 10.1016/s0378-5122(98)00008-5.
8
Specific changes of urinary excretion of cross-linked N-telopeptides of type I collagen in pre- and postmenopausal women: correlation with other markers of bone turnover.绝经前和绝经后女性I型胶原交联N-端肽尿排泄的特定变化:与其他骨转换标志物的相关性
Calcif Tissue Int. 1997 Apr;60(4):317-22. doi: 10.1007/s002239900235.
9
The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.骨转换生化标志物对日本绝经后女性骨密度的预测价值。
J Bone Miner Res. 2000 Aug;15(8):1537-44. doi: 10.1359/jbmr.2000.15.8.1537.
10
The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60.60岁以下绝经后女性循环胰岛素样生长因子成分、骨转换生化标志物与骨密度之间的关系。
Clin Endocrinol (Oxf). 1999 Sep;51(3):301-7. doi: 10.1046/j.1365-2265.1999.00769.x.

引用本文的文献

1
FABP4 inhibition suppresses bone resorption and protects against postmenopausal osteoporosis in ovariectomized mice.脂肪酸结合蛋白4(FABP4)抑制可抑制去卵巢小鼠的骨吸收并预防绝经后骨质疏松症。
Nat Commun. 2025 May 13;16(1):4437. doi: 10.1038/s41467-025-59719-w.
2
Identification of Risk Factors for Primary Osteoporosis: The Role of Cervical Ligament Ossification.原发性骨质疏松症的危险因素识别:颈椎韧带骨化的作用。
Med Sci Monit. 2024 Aug 29;30:e944963. doi: 10.12659/MSM.944963.
3
Effects of daily probiotic supplementation with on calcium status, bone metabolism biomarkers, and bone mineral density in postmenopausal women: a controlled and randomized clinical study.
每日补充益生菌对绝经后女性钙状态、骨代谢生物标志物及骨密度的影响:一项对照随机临床研究。
Front Nutr. 2024 Jul 1;11:1401920. doi: 10.3389/fnut.2024.1401920. eCollection 2024.
4
Progress in Prevention and Treatment of Acute Bone Loss in Orthopedics.骨科急性骨丢失的防治进展
Int J Endocrinol. 2023 Nov 30;2023:9373043. doi: 10.1155/2023/9373043. eCollection 2023.
5
capsules reduce bone loss in the subchondral bone of rats with comorbid osteoporosis and osteoarthritis by regulating metabolite alterations.胶囊通过调节代谢物变化减少合并骨质疏松症和骨关节炎大鼠软骨下骨的骨质流失。
Front Med (Lausanne). 2023 Oct 17;10:1256238. doi: 10.3389/fmed.2023.1256238. eCollection 2023.
6
Hormone-Related and Drug-Induced Osteoporosis: A Cellular and Molecular Overview.激素相关性和药物性骨质疏松症:细胞与分子概述。
Int J Mol Sci. 2023 Mar 18;24(6):5814. doi: 10.3390/ijms24065814.
7
Risk factors of vertebral re-fracture after PVP or PKP for osteoporotic vertebral compression fractures, especially in Eastern Asia: a systematic review and meta-analysis.经皮椎体后凸成形术(PVP)或经皮椎体成形术(PKP)治疗骨质疏松性椎体压缩骨折后椎体再骨折的风险因素,特别是在东亚:系统评价和荟萃分析。
J Orthop Surg Res. 2022 Mar 12;17(1):161. doi: 10.1186/s13018-022-03038-z.
8
Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover.激素失衡导致的骨质疏松症:雌激素缺乏和糖皮质激素过度使用对骨代谢的影响概述。
Int J Mol Sci. 2022 Jan 25;23(3):1376. doi: 10.3390/ijms23031376.
9
Association Between Alkaline Phosphatase and Clinical Outcomes in Patients With Spontaneous Intracerebral Hemorrhage.自发性脑出血患者碱性磷酸酶与临床结局的关联
Front Neurol. 2021 Aug 30;12:677696. doi: 10.3389/fneur.2021.677696. eCollection 2021.
10
Potential of biomarkers during pharmacological therapy setting for postmenopausal osteoporosis: a systematic review.绝经后骨质疏松症药物治疗中生物标志物的潜力:系统评价。
J Orthop Surg Res. 2021 May 31;16(1):351. doi: 10.1186/s13018-021-02497-0.